“The sale of Emanate is consistent with the growth strategy of direction of the Shine Justice Group,” Shine stated.

“As previously announced, we are pursuing organic and acquisition growth opportunities that meet our investment criteria and anticipate strong growth in several of our practice areas, including personal injuries, class actions, abuse law and medical law.”

According to the firm website, Emanate “endeavours to develop and maintain long-term relationships with clients so that we become integrated with their business.

VIEW ALL

“An intimate knowledge of your situation allows us to take a proactive approach, helping you to add value to your product or service, expand your business and ultimately increase your profitability,” it stated.

The sale will enable Shine to recover its investment in Emanate, subject to a collection of work in progress and debtors on Emanate files over a five-year period. The sale is expected to be complete later this month. 

Speaking to Lawyers Weekly, Simon Morrison, managing director of Shine Justice, said that the sale was a “strategic decision”. 

“Shine Justice made a strategic decision to prioritise parts of the business we see growing substantially in the future,” he said. 

“As a business, we will be concentrating on both organic and acquisitive opportunities connected to this growth plan.”

The Lawyers Weekly Jobs Board has had a refresh! To check out the latest opportunities in private practice, in-house and more, click here.